|
|
Volumn 8, Issue 10, 2002, Pages 1048-
|
|
Company pushes broad-ranging patent claim
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BORTEZOMIB;
DROTRECOGIN;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
PROTEASOME INHIBITOR;
RALOXIFENE;
UNCLASSIFIED DRUG;
AUTOIMMUNE DISEASE;
BONE ATROPHY;
CARDIOVASCULAR DISEASE;
DRUG MECHANISM;
HUMAN;
INFLAMMATORY DISEASE;
LAW SUIT;
LICENSING;
MULTIPLE MYELOMA;
NONHUMAN;
NOTE;
PATENT;
PRIORITY JOURNAL;
SEPSIS;
SIGNAL TRANSDUCTION;
TRANSCRIPTION REGULATION;
|
|
EID: 0036796115
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm1002-1048a Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|